AR and prostate cancer: Because the sFRP1 CRD competes with Frizzled receptors for binding to Wnts (Lin et al, 1997; Bafico et al, 1999), we hypothesised that sFRP1 represses AR by antagonising autocrine Wnt signals in prostate cancer cells.